Article - MRI With AI Can Improve Prognosis, Treatment for Glioblastoma

In the first study of its kind in cancer, researchers have applied artificial intelligence to measure the amount of muscle in patients with brain tumours to help improve prognosis and treatment. Dr Ella Mi, a clinical research fellow at Imperial College London (UK) told the NCRI Virtual Showcase, that using deep learning to evaluate MRI brain scans of a muscle in the head was as accurate and reliable as a trained person, and was considerably quicker. Furthermore, her research showed that the amount of muscle measured in this way could be used to predict how long a patient might survive their disease as it was an indicator of a patient's overall condition. Glioblastoma is an aggressive brain tumour that is very difficult to treat successfully. Average survival after diagnosis is 12-18 months and fewer than 5% of patients are still alive after five years.